Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
GO:0005783 | endoplasmic reticulum | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
Related structures:
AlphaFold database: E9B581
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.421 |
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.655 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.417 |
CLV_PCSK_KEX2_1 | 75 | 77 | PF00082 | 0.592 |
CLV_PCSK_SKI1_1 | 14 | 18 | PF00082 | 0.316 |
CLV_PCSK_SKI1_1 | 46 | 50 | PF00082 | 0.303 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.333 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.575 |
DEG_SCF_FBW7_2 | 65 | 72 | PF00400 | 0.401 |
DOC_CKS1_1 | 66 | 71 | PF01111 | 0.375 |
DOC_MAPK_DCC_7 | 49 | 59 | PF00069 | 0.337 |
DOC_MAPK_gen_1 | 45 | 55 | PF00069 | 0.422 |
DOC_MAPK_MEF2A_6 | 45 | 54 | PF00069 | 0.422 |
DOC_USP7_UBL2_3 | 41 | 45 | PF12436 | 0.567 |
DOC_WW_Pin1_4 | 65 | 70 | PF00397 | 0.456 |
LIG_FHA_1 | 35 | 41 | PF00498 | 0.617 |
LIG_FHA_2 | 66 | 72 | PF00498 | 0.394 |
LIG_SH2_STAP1 | 81 | 85 | PF00017 | 0.334 |
LIG_SH3_3 | 50 | 56 | PF00018 | 0.333 |
LIG_TRAF2_1 | 69 | 72 | PF00917 | 0.342 |
MOD_CK2_1 | 65 | 71 | PF00069 | 0.384 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.442 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.604 |
MOD_GSK3_1 | 28 | 35 | PF00069 | 0.630 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.587 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.530 |
MOD_NEK2_1 | 16 | 21 | PF00069 | 0.512 |
MOD_Plk_1 | 32 | 38 | PF00069 | 0.582 |
MOD_ProDKin_1 | 65 | 71 | PF00069 | 0.461 |
MOD_SUMO_for_1 | 40 | 43 | PF00179 | 0.517 |
TRG_ER_diArg_1 | 12 | 15 | PF00400 | 0.632 |
TRG_ER_diArg_1 | 75 | 78 | PF00400 | 0.459 |
TRG_Pf-PMV_PEXEL_1 | 7 | 11 | PF00026 | 0.366 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5F0 | Leptomonas seymouri | 70% | 100% |
A0A0S4J4S3 | Bodo saltans | 53% | 100% |
A0A3Q8INJ8 | Leishmania donovani | 93% | 100% |
A4HB11 | Leishmania braziliensis | 83% | 100% |
A4IA68 | Leishmania infantum | 92% | 100% |
C9ZM38 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
Q4Q2Q2 | Leishmania major | 94% | 100% |